Diagnosis and Treatment of Osteoporosis in High-Risk Patients Prior to Hip Fracture

Geriatric Orthopaedic Surgery & Rehabilitation

Volumn 3, Issue 2, 2012, Pages 79-83

  Gleason, Lauren J ^a   Menzies, Isaura B ^b   Mendelson, Daniel A ^a   Kates, Stephen L ^a   Friedman, Susan M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

dementia; fragility fractures; geriatric medicine; hip fracture; metabolic bone disorders; osteoporosis

Indexed keywords

EID: 84993737918     PISSN: 21514585     EISSN: 21514593     Source Type: Journal    
DOI: 10.1177/2151458512454878     Document Type: Article

References (30)

1. Morris AH Zuckerman JD. National Consensus Conference on improving continuum of care for patients with hip fracture. J Bone Joint Surg Am. 2002; 84-A(4):670–674.
2. Braithwaite RS Col NF Wong JB. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc. 2003; 51(3):364–370.
3. Magaziner J Hawkes W Hebel JR, et al. Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci. 2000; 55(9):M498–M507.
4. Nelson HD Haney EM Dana T Bougatsos C Chou R. Screening for osteoporosis: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2010; 153(2):99–111.
5. Center JR Bliuc D Nguyen TV Eisman JA. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA. 2007; 297(4):387–394.
6. Jennings LA Auerbach AD Maselli J Pekow PS Lindenauer PK Lee SJ. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture. J Am Geriatr Soc. 2010; 58(4):650–657.
7. Haasum Y Fastborn J Fratiglioni L Johnell K. Undertreatment of osteoporosis in persons with dementia? A population-based study. Osteoporos Int. 2012; 23(3):1061–1068.
8. Menzies IB Mendelson DA Kates SL Friedman SM. The prevention and clinical management of hip fractures in patients with dementia. Geriatr Orthop Surg Rehabil. 2010; 1(2):63-72.
9. Friedman SM Menzies IB Bukata SV Mendelson DM Kates SL. Dementia and hip fractures: development of a pathogenic framework for understanding and studying risk. Geriatr Orthop Surg Rehabil. 2010; 1(2):52–62.
10. Melton LJ III Beard CM Kokmen E Atkinson EJ O'Fallon WM. Fracture risk in patients with Alzheimer's disease. J Am Geriatr Soc. 1994; 42(6):614–619.
11. Herbert LE Scherr PA Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA. 1995; 273(17):1354–1359.
12. Lloyd BD Williamson DA Singh NA, et al. Recurrent and injurious falls in the year following hip fracture: a prospective study of incidence and risk factors from the Sarcopenia and Hip Fracture Study. J Gerontol A Biol Sci Med Sci. 2009; 64(5):599–609.
13. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001; 285(6):785–795.
14. Qaseem A Snow V Shekelle P Hopkins R Jr Forciea MA Owens DK. Pharmacologic treatment of low bone density or osteoporosis to prevent fracture: a clinical practice guideline from American College of Physicians. Ann Intern Med. 2008; 149(6):404–415.
15. Johnell K Fastbom K. Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people. Arch Osteoporos. 2009; 4(1-2):17–23.
16. Rabenda V Vanoverloop J Fabri V, et al. Low Incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg Am. 2008; 90(10):2142–2148.
17. Charlson ME Pompei P Ales KL MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373–383.
18. McNally DN Kenny AM Smith JA. Adherence of academic geriatric practitioners to osteoporosis screening guidelines. Osteoporos Int. 2007; 18(2):177–183.
19. National Osteoporosis Foundation Web site. http://www.nof.org/sites/default/files/bonebasics/BoneBasicsAlert_BMDTest.pdf. Accessed October 18, 2011.
20. Siris ES Chen YT Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004; 164(10):1108–1112.
21. Wylie CD. Setting a standard for a “silent” disease: defining osteoporosis in the 1980s and 1990s. Stud Hist Philos Biol Biomed Sci. 2010; 41(4):376–385.
22. Kamel HK Hussain MS Tariq S Perry HM Morley JE. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med. 2000; 109(4):326–328.
23. Chapuy MC Arlot ME Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med. 1992; 327(23):1637–1642.
24. Dawson-Hughes B Harris SS Krall EA Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997; 337(10):670–676.
25. Patrick AR Brookhart MA Losina E, et al. The complex relation between bisphosphonate adherence and fracture reduction. J Clin Endocrinol Metab. 2010; 95(7):3251–3259.
26. Sato Y Kanoko T Satoh K Iwamoto J. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. Arch Intern Med. 2005; 165(15):1737–1742.
27. Pham AN Datta SK Weber TJ Walter LC Colón-Emeric CS. Cost-effectiveness of oral bisphosphonates for osteoporosis at different ages and levels of life-expectancy. J Am Geriatr Soc. 2011; 59(9):1642–1649.
28. Brauner DJ Muir JC Sachs GA. Treating nondementia illnesses in patients with dementia. JAMA. 2000; 283(24):3230–3235.
29. Boyd CM Darer J Boult C Fried LP Boult L Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA. 2005; 294(6):716–724.
30. Wainwright SA Marshall LM Ensrud KE, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005; 90(5):2787–2793.